Atlas Trials

Terlipressin Administration in Septic Shock Refractory to Catecholamines

Clinical trial NCT00793559 · UNKNOWN

Trial details

NCT number
NCT00793559
Sponsor
Assaf-Harofeh Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Septic Shock
Start date
2008-11-01
Primary completion
2009-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.